Clobetasol Propionate: Package Insert and Label Information (Page 3 of 3)
PRINCIPAL DISPLAY PANEL – 0.05%
FOR TOPICAL USE ONLY.
NOT FOR OPHTHALMIC, ORAL,
OR INTRAVAGINAL USE.
Shake can before use.
Description: Each gram of Clobetsol
Propionate Foam contains 0.5 mg
clobetasol propionate, USP.
The foam also contains anhydrous
citric acid, cetyl alcohol,
cyclomethicone, isopropyl myristate,
light mineral oil, polyoxyl 20
cetostearyl ether, potassium citrate
monohydrate, propylene glycol,
purified water, sorbitan monolaurate,
white petrolatum, and phenoxyethanol
as a preservative, and is pressurized
with a hydrocarbon (propane/butane)
Usual Dosage: Use only as
prescribed by your physician. See
Warning: FLAMMABLE. AVOID FIRE,
FLAME, OR SMOKING DURING AND
Contents under pressure. Do not
puncture or incinerate. Do not
expose to heat or store at
temperatures above 120°F (49°C).
Avoid contact with eyes or other
mucous membranes. Keep this and
all medication out of the reach of
Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.
DPT Laboratories, Ltd.
San Antonio, TX 78215 U.S.A.
For more information, call
Mylan Pharmaceuticals Inc. at1-877-446-3679 (1-877-4-INFO-RX).
|CLOBETASOL PROPIONATE clobetasol propionate aerosol, foam|
|Labeler — Mylan Pharmaceuticals Inc. (059295980)|
Revised: 05/2018 Mylan Pharmaceuticals Inc.
DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.